Cervical Cancer, Breast Cancer, Colorectal Cancer Screenings Figures Reveal Racial, Ethnic Disparities

The number of U.S. adults getting screened for cervical cancer, breast cancer and colorectal cancer is not meeting targets, especially among Asian and Hispanic Americans, federal health officials found.

Dosing Begins for GOG US Cervical Cancer Study Evaluating ADXS-HPV

Advaxis, Inc., , a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced at the OneMedForum in San Francisco that patient dosing has begun in the Gynecologic Oncology Group 67 patient Phase 2 study evaluating Advaxis’ ADXS-HPV construct for the treatment of advanced cervical cancer.

Advaxis Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer

Advaxis, Inc., , a leader in developing the next generation of immunotherapies for cancer and infectious diseases, reported preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy.

REPEAT/Advaxis Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer

Advaxis, Inc., , a leader in developing the next generation of immunotherapies for cancer and infectious diseases, reported preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy.

January is Cervical Cancer Awareness month

CRYSTAL LAKE – Gov. Pat Quinn has issued a proclamation recognizing January as Cervical Cancer Awareness Month.